Nutromics Pty Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Nutromics Pty Ltd - overview

Established

2017

Location

Melbourne, VIC, Australia

Primary Industry

Medical Devices & Equipment

About

Nutromics Pty Ltd was founded in 2017 in Melbourne, Australia. The company focuses on the development of advanced diagnostic monitoring devices. Co-founded by Hitesh Mehta and Peter Vranes (CEO). In June 2023, Nutromics Pty Ltd raised USD 7 million in pre-series A funding from investors.


Nutromics specializes in the Lab-on-a-Patch®, a continuous diagnostic monitoring device that uses DNA-based sensors and microneedles for real-time biochemistry analytics. This device addresses healthcare challenges by enabling timely diagnostics and continuous monitoring, primarily targeting healthcare providers and clinics across North America, Europe, and Asia. Nutromics operates a business model centered on partnerships and direct sales in the healthcare sector, with revenue generated from the sale of the Lab-on-a-Patch® to healthcare institutions. The company anticipates ongoing transactions with hospitals and clinics, potentially supported by subscription models for data analytics services.


Current Investors

CP Ventures, Artesian, Kz 7 Pty Ltd

Primary Industry

Medical Devices & Equipment

Sub Industries

Therapeutic Devices, Monitoring Equipment, Diagnostic Equipment

Website

www.nutromics.com

Verticals

HealthTech, Manufacturing, Wearables & Quantified Self

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.